Monte Rosa Therapeutics, Inc. (GLUE) Technical Analysis

🔺 Technical Setup

🎯 Decision Map

The nearest decision zone is framed by support around 18.18 and resistance near 21.27. A cleaner push through resistance would improve continuation odds, while a loss of support would weaken the current thesis. Pattern invalidation sits near 26.54, so a violation there would materially change the current setup narrative.

📊 Technical Summary

The latest close for Monte Rosa Therapeutics, Inc. (GLUE) came in at 19.15 (+2.30%). Price continues to hold above both the 50-day and 200-day moving averages, which keeps the broader trend structure constructive. 20-day momentum is notably strong at +11.53%, with price remains inside its roughly 52-week range (3.70–25.31), while ATR14 volatility is elevated at roughly 5.38% of price. RSI(14) is 55.6, leaving momentum in a fairly neutral range. RSI has been trending higher in recent sessions, indicating improving momentum conditions. MACD remains below its signal line, which shows that momentum confirmation is still limited. The MACD histogram is negative and weakening further, which reflects continued downside pressure. Recent trading volume is running below its typical 20-day average, which suggests participation remains relatively muted. Near-term structure is defined by support at 18.18 and resistance at 21.27. A clean break above resistance would strengthen the chart, while a loss of support would put the current setup under pressure. Fundamentals snapshot: Revenue: 12.77M · Net income: -27.08M. The interactive chart adds overlays, pattern context and a fuller structure view for deeper review.

Explore more